General screening for volunteers in infectious disease studies
Official title: General Pre-Trial Screening Protocol for Enrollment of Volunteers Into Infectious Diseases Research Protocols
Run by Beth Israel Deaconess Medical Center · NCT06463704 · Data updated 2026-11-12
This study is looking for healthy adults to volunteer for upcoming vaccine and treatment trials by checking if they meet the necessary health criteria.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 250 (estimated) |
| Sponsor | Beth Israel Deaconess Medical Center Academic / other |
| Locations | 1 site (Boston, Massachusetts) |
| Status | Recruiting |
| Started | June 21, 2024 |
| Main results expected | June 2029 |
| Study ends | June 2034 |
| Registry record updated | April 8, 2026 |
| Trial ID | NCT06463704 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are healthy adults aged 18 years or older who are interested in participating in clinical trials.
✕Probably not a fit
Patients with serious health conditions requiring active medical intervention or monitoring may not benefit from this screening protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This protocol is designed to facilitate the recruitment of healthy adult volunteers for various clinical trials at the Center for Virology and Vaccine Research and the Division of Infectious Diseases at Beth Israel Deaconess Medical Center. It involves a prescreening process, which may include a telephone interview and an in-person clinic visit, to assess the eligibility of participants for upcoming vaccine or therapeutic trials. The screening will include safety evaluations such as physical exams, vital signs, and laboratory tests to ensure participants meet the necessary criteria for inclusion in specific studies.
Why it matters
Potential benefit: If successful, this protocol could streamline the recruitment process for clinical trials, leading to faster enrollment and potentially more effective treatments for infectious diseases.
How similar studies have gone: Other studies utilizing similar prescreening protocols have shown success in efficiently recruiting participants for clinical trials.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years of age or older at time of consent * Available to participate for the planned duration of the clinical trials for which screening is being done * Capable of giving signed informed consent Exclusion Criteria: • A condition, based on clinical judgement, which requires active medical intervention or monitoring to avert serious danger to the participant's health or well-being
Where it's running
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States Recruiting
Study contacts
- Study coordinator: Kathryn E Stephenson, MD, MPH
- Email: kstephen@bidmc.harvard.edu
- Phone: 617-735-4556
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Daily 7-Minute Digital Meditation for Young Adults
A short daily, app-based meditation test in 18-40 year-olds in the US to see if it improves mood, stress, and well-being.
-
How regular meditation relates to thinking and emotion control
This study will see if people who regularly practice Isha-style meditation differ in cognitive skills and emotion regulation compared with people who do not meditate.
-
Measuring muscle health with a handheld electrical impedance device (mScan)
This project will test whether a handheld mScan device can quickly measure muscle health in adults with myopathies and in people without muscle disease by comparing its readings to MRI.
-
Reverse leftover spinal numbness after knee or hip replacement with an intrathecal saline flush
This study tests whether injecting a small amount of sterile saline through a spinal catheter can quickly reduce or eliminate leftover spinal anesthesia in adults having elective lower-extremity joint replacement.
-
Seeing if DCog Short on an iPad can spot neurotoxicity in CAR-T patients
This study tests whether a self-report iPad tool called DCog Short can help identify neurotoxicity in people receiving CAR-T cell therapy.
-
DC/MM fusion vaccine plus BCMA CAR-T for relapsed or refractory multiple myeloma
This trial will test whether adding a personalized DC/MM fusion vaccine (with GM‑CSF) to standard BCMA CAR‑T therapy helps people with relapsed or refractory multiple myeloma.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.